1 |
Mun JB. Usefulness of Anti-mullerian Hormone for the Diagnosis of Polycystic Ovary Syndrome. Department of Medicine, Graduate school, Wonkwang university. 2014.
|
2 |
Seopgye(葉桂). Seopcheonsayeogwa(葉天士女科). Seoul:Daeseongmunhwasa. 1995:14-5.
|
3 |
Shin MK. Clinical Traditional Herbalogy. 2nd rev. ed. Seoul:Youngrimsa. 2010:213-558.
|
4 |
Oh TG, et al. Clinical Study for the One Case that Diagnosed Polycystic Ovarian Disease. The Journal Of Oriental Obstetrics & Gynecology. 2008;21(2):284-91.
|
5 |
Kim JR, et al. Clinical Study for the Four Cases of Secondary Amenorrhea and Hypomenorrhea by Hormone Assay. The Journal Of Oriental Obstetrics & Gynecology. 2009;22(3):267-76.
|
6 |
Korean Society of Obstetrics and Gynecology. Gynecology. 5th ed. Seoul: Korea Medical Book Publishing Company. 2015:81-493.
|
7 |
Kim JH, et al. A Study on the Characters of Oligomenorrheic Patients by Through Comparison of BMI, Yangorak, Menarche of Normal Menstrual Cycle Group and Oligomenorrheic Group. The Journal of Oriental Obstetrics & Gynecology. 2011;24(3):85-97.
|
8 |
Lee HY, Sung YH. Epidemiology and Diagnostic Criteria of Polycystic Ovary Syndrome. J Korean Diabetes. 2015;16(3):189-93.
DOI
|
9 |
You SY, et al. Anti-mullerian Hormone in Women with Polycystic Ovary Syndrome. Korean J obestet Gynecol. 2012;55(5):315-24.
DOI
|
10 |
Dumont A, et al. Role of Anti-Mullerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review. Reproductive Biology and Endocrinology. 2015;13(1):137.
DOI
|
11 |
Song DK, et al. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Mullerian hormone cutoff value. Korean J Intern Med. 2017;32(4):690-8.
DOI
|
12 |
Dewailly D, et al. Reconciling the Definitions of Polycystic Ovary Syndrome: The Ovarian Follicle Number and Serum Anti-Mullerian Hormone Concentrations Aggregate with the Markers of Hyperandrogenism. J Clin Endocrinol Metab. 2010;95(9):4399-405.
DOI
|
13 |
Sung YH. Medical Diagnosis and Treatment of Polycystic Ovary Syndrome. The Korean Journal of Medicine. 2006;70(4):356-60.
|
14 |
Balen A, Conway G, Kaltsas G. Polycystic Ovary Syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10(8):2107-11.
DOI
|
15 |
Sirmans SM, Pate KA. Epidemiology, Diagnosis, and Management of Polycystic Ovary Syndrome. Clinical Epidemiology. 2013;6(default):1-13.
|
16 |
The society of Korean medicine obstetrics and gynecology. Korean medicine obstetrics and gynecology. 3rd ed. Seoul:Uiseongdang. 2016:31-191.
|
17 |
Sung YA. Polycystic Ovary Syndrome in Korean Women: Clinical Characteristics and Diagnostic Criteria. Enadocrinol Metab. 2011;26(3):203-7.
DOI
|
18 |
Fauser B, et al. Consensus on Women's Health Aspects of Polycystic Ovary Syndrome(PCOS): the Amsterdam ESHRE/ASRM-sponsored 3rd PCOS Consensus Workshop Group. Fertil Steri. 2012;97(1):28-38.e25.
DOI
|
19 |
Yun SY, Kang MJ. Clinical Study of Oriental Medicine Treatment for Polycystic Ovarian Disease. The Journal Of Oriental Obstetrics & Gynecology. 2000;13(2):437-51.
|
20 |
Bili H. et al. Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years. Eur J Endocrinol. 2001;145(6):749-55.
DOI
|
21 |
Moran C, et al. Adrenal androgen excess and body mass index in polycystic ovary syndrome. J Clin Endocrinol Metab. 2015;100(3):942-50.
DOI
|
22 |
Lee JR, Kim SH. Anti-Mullerian hormone and female reproduction. Korean J Obstet Gynecol. 2009;52(3):285-300.
|
23 |
La Marca A, et al. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril. 2004;82(4):970-2.
DOI
|
24 |
Pigny P, et al. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(3):941-5.
DOI
|
25 |
Li L, et al. Elevated serum antimullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome. Wien Klin Wochenschr. 2010;122(17-18):519-24.
DOI
|
26 |
Woo HY, et al. Differences of the association of anti-Mullerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. Endocr J. 2012;59(9):781-90.
DOI
|